Skip to main content

Pharma-Bio Serv, Inc. (PBSV) Stock Forecast 2025 - AI Price Prediction & Analysis


Pharma-Bio Serv, Inc. (PBSV) AI Stock Price Forecast & Investment Analysis

Pharma-Bio Serv, Inc. Stock Price Chart and Technical Analysis

Loading Pharma-Bio Serv, Inc. interactive price chart and technical analysis...

Pharma-Bio Serv, Inc. (PBSV) - Comprehensive Stock Analysis & Investment Research

Deep dive into Pharma-Bio Serv, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Pharma-Bio Serv, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Pharma-Bio Serv, Inc.: Pharma-Bio Serv, Inc. operates in the Trade & Services sector, making it an emerging small-cap investment.

Pharma-Bio Serv, Inc. (Stock Symbol: PBSV) is a leading company in the Trade & Services sector , specifically operating within the Services-Management Consulting Services industry.

.

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Pharma-Bio Serv, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Pharma-Bio Serv, Inc.: With $9M in annual revenue, the company demonstrates developing profitability.

Annual Revenue: $9 million .

Market Capitalization: $14 million - Classified as a small-cap investment offering high growth potential.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Pharma-Bio Serv, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Pharma-Bio Serv, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Pharma-Bio Serv, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Pharma-Bio Serv, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Pharma-Bio Serv, Inc.: Market positioning analysis based on available financial and operational metrics.

Pharma-Bio Serv, Inc. strategically competes in the highly dynamic Services-Management Consulting Services marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

Pharma-Bio Serv, Inc. (PBSV) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Pharma-Bio Serv, Inc. stock analysis.

Loading Pharma-Bio Serv, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into Pharma-Bio Serv, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Pharma-Bio Serv, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Pharma-Bio Serv, Inc.:

P/B Ratio 1.17x
Market Cap $14M
Book Value/Share $0.52
Revenue/Share $0.40
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Pharma-Bio Serv, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Pharma-Bio Serv, Inc.:

Understanding Financial Health Metrics

What these metrics mean: These ratios assess Pharma-Bio Serv, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Pharma-Bio Serv, Inc.:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Pharma-Bio Serv, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Pharma-Bio Serv, Inc.:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Pharma-Bio Serv, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Pharma-Bio Serv, Inc.:

Understanding Financial Statement Data

What these metrics mean: Key figures from Pharma-Bio Serv, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Pharma-Bio Serv, Inc.: With annual revenue of $9M, Pharma-Bio Serv, Inc. represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $9M
Balance Sheet Highlights (% Of Assets)
Dividend & Shareholder Information
Shares Outstanding 23M

Latest Pharma-Bio Serv, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Pharma-Bio Serv, Inc. (PBSV) stock price and investment outlook.

, source: Nasdaq

DORADO, PUERTO RICO / ACCESS Newswire / January 29, 2025 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory affairs, quality, compliance, project management and ...

, source: Benzinga.com

There are no upcoming dividends for Pharma-Bio Serv.The last dividend paid last dividend payout March 20, 2025 and was $0.08. Pharma-Bio Serv has no upcoming dividends reported. The last reported ...

Pharma-Bio Serv, Inc. Competitors & Peer Analysis - Trade & Services Sector

Comparative analysis of Pharma-Bio Serv, Inc. against industry peers and competitors in the Trade & Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ACCS Unlock Forecast - 30 Days FREE Trial $39M x 1.3x
ASTH Unlock Forecast - 30 Days FREE Trial $1610M 64.5x 2.1x
BAH Unlock Forecast - 30 Days FREE Trial $10107M 24.2x 10.2x
BWMN Unlock Forecast - 30 Days FREE Trial $737M -54.4x 3.0x
CISO Unlock Forecast - 30 Days FREE Trial $40M -1.2x 5.3x
CTM Unlock Forecast - 30 Days FREE Trial $87M -0.9x 2.7x
EUBG Unlock Forecast - 30 Days FREE Trial $233M 418.1x 25.8x
EXPO Unlock Forecast - 30 Days FREE Trial $3374M 34.8x 7.9x
FCN Unlock Forecast - 30 Days FREE Trial $5291M 18.4x 3.0x
G Unlock Forecast - 30 Days FREE Trial $6603M 12.9x 2.6x
GFLT Unlock Forecast - 30 Days FREE Trial $112M x 378.5x
GLVT Unlock Forecast - 30 Days FREE Trial $8M x x
HCKT Unlock Forecast - 30 Days FREE Trial $517M 31.8x 4.3x
HURN Unlock Forecast - 30 Days FREE Trial $3057M 26.4x 6.1x
ICFI Unlock Forecast - 30 Days FREE Trial $1577M 22.1x 1.6x
III Unlock Forecast - 30 Days FREE Trial $264M 34.9x 2.8x
IVHI Unlock Forecast - 30 Days FREE Trial $3M x x
LICN Unlock Forecast - 30 Days FREE Trial $1M x 0.0x
MEG Unlock Forecast - 30 Days FREE Trial $934M -10.2x 2.0x
MHH Unlock Forecast - 30 Days FREE Trial $83M 95.3x 0.9x
PBSV Unlock Forecast - 30 Days FREE Trial $14M x 1.2x
PNPL Unlock Forecast - 30 Days FREE Trial $9M x x
RMR Unlock Forecast - 30 Days FREE Trial $464M 15.2x 2.0x
ROMA Unlock Forecast - 30 Days FREE Trial $34M x 0.6x
SATT Unlock Forecast - 30 Days FREE Trial $1M 0.5x x
SSHT Unlock Forecast - 30 Days FREE Trial $9M x x
TSSI Unlock Forecast - 30 Days FREE Trial $427M 85.2x 44.8x
WHLM Unlock Forecast - 30 Days FREE Trial $15M 27.0x 0.6x
ZBAI Unlock Forecast - 30 Days FREE Trial $145M x 17.3x

Frequently Asked Questions - Pharma-Bio Serv, Inc. Stock Forecast

How accurate are Pharma-Bio Serv, Inc. stock predictions?

Our AI model shows a 44% Spearman correlation coefficient for PBSV predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Pharma-Bio Serv, Inc. stock price forecasts?

Our analysis considers Pharma-Bio Serv, Inc.'s financial metrics, Trade & Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Pharma-Bio Serv, Inc. a good investment in 2025?

Based on our AI analysis, Pharma-Bio Serv, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Pharma-Bio Serv, Inc. forecasts updated?

Pharma-Bio Serv, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Pharma-Bio Serv, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Pharma-Bio Serv, Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...